Over the decades, immense
research in Biomedicine has been provided an accurate and deep understanding
related to lethal diseases such as Cancer, HIV and Myocardial infarction;
however, the complexity of disease and difference from individual to
individual, it is difficult to diagnose at early stage and treatment. To
fulfill the gap personalized medicine has been introduced, which is defined as
‘tailoring or monitoring of diagnosis and therapies to the genetic profile of
an individual’.
In recent past, there is an
increased interest in Nanotechnology and nanomedicine, which refers to the
study of phenomena
and the manipulation of matter at the atomic and molecular level. The vision
of this technology is to improve productivity, health care, human potential and
sociality issues such as higher limits of sustainable development. Nanoscience,
evolved to the next levels and used as potential environmental monitoring
agents like nanostructured gas sensors and for medical applications,
particularly as drug delivery systems.
Personalized nanomedicine is designing of
novel nanomaterials with increased binding affinity, controlled navigation,
sustained release of drug, good biocompatibility, and maximum therapeutic
potential which are crucial for effective theranostic approaches. It may
defined as combining noninvasive imaging
with targeted drug delivery seems to hold significant potential for
personalizing nanomedicine-based chemotherapeutic interventions, to achieve
delivery of the right drug to the right location in the right patient at the
right time.
No comments:
Post a Comment